Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 20, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Editorial

Jason Lohmueller1, Sandra Cascio2

  • 1Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15232, USA.

Cellular Immunology
|August 27, 2019
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 20, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Related Concept Videos

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

8.7K
In the past many in vitro culture systems -- mainly monolayer cultures -- often suffered from the disadvantage that differentiated primary cells had a relatively short life-span and de-differentiated during culture. As a consequence, most of their organ-specific functions were lost rapidly. Thus, in order to reproduce better conditions for these cells in vitro, modifications and adaptations have been made to conventional monolayer...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel humanized immune stroma PDX cancer model for therapeutic studies.

Cancer immunology, immunotherapy : CII·2026
Same author

Small-molecule control of CAR T cells.

Nature reviews. Chemistry·2025
Same author

Murine cell lines with defined mutations model different histological subtypes of epithelial ovarian cancer.

Disease models & mechanisms·2025
Same author

Conditional Control of Benzylguanine Reaction with the Self-Labeling SNAP-tag Protein.

Bioconjugate chemistry·2025
Same author

Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions.

Antibodies (Basel, Switzerland)·2024
Same author

Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cells.

The Journal of clinical investigation·2024
Same journal

The uptake, intracellular trafficking and recycling of FcRn-blocking therapeutics in human endothelial cells in vitro.

Cellular immunology·2026
Same journal

Exosome-mediated immune modulation in rheumatoid arthritis and its role in synovial inflammation and autoimmune amplification.

Cellular immunology·2026
Same journal

Persistent CD4<sup>+</sup> T cell hyporesponsiveness during recovery from prolonged symptomatic SARS-CoV-2 infection.

Cellular immunology·2026
Same journal

Deficit in blood MAIT cells, altered cytokines and T cell dynamics in patients with coronary artery disease.

Cellular immunology·2026
Same journal

The circ_0003692-miR-1197-TLR4 axis: A key regulator in rheumatoid arthritis proliferation and inflammation.

Cellular immunology·2026
Same journal

IGF2BP2 promotes cuproptosis of cardiomyocytes through m<sup>6</sup>A modification of MAP2K1 in sepsis-induced myocardial injury.

Cellular immunology·2026
See all related articles